Catalyst Wire Dossier Catalyst Wire Dossier

Apidra (insulin glulisine)

insulin glulisine · Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Apidra (insulin glulisine), covering 2017-01-04 to 2017-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients [Phase 3]

See pricing